Lawrence Klein
Vermogen: 54 M $ op 31-05-2026
Vermogen: 54 M $ op 31-05-2026
Lawrence O. Klein is lid van de raad van bestuur van Dyne Therapeutics, Inc. en Chief Operating & Business Officer bij CRISPR Therapeutics AG. Dr. Klein was voorheen Associate Partner bij Mckinsey & Co. (Zwitserland). Dr. Klein behaalde een doctoraat aan de Stanford University en een bachelor aan de University of Wisconsin.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
1,91% | 15-06-2026 | 925.580 ( 1,91% ) | 54 M $ | 31-05-2026 |
| 09-06-2026 | 70 ( 0% ) | 1 473 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| JADE BIOSCIENCES, INC. | Directeur/Bestuurslid | 28-04-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 01-02-2024 |
| JASPER THERAPEUTICS, INC. | Directeur/Bestuurslid | 20-06-2023 |
| DYNE THERAPEUTICS, INC. | Directeur/Bestuurslid | 24-05-2023 |
| CRISPR THERAPEUTICS AG | Operationeel Directeur | 01-10-2022 |
Mckinsey & Co. (Switzerland)
Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Corporate Officer/Principal | 01-02-2016 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Mckinsey & Co. (Switzerland)
Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau